Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Terri B. Sebree currently holds 255,000 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terri B. Sebree has been a net seller of ZYNE stock. They have purchased $22.0K and sold $40.4K worth of shares.
Terri B. Sebree's most recent insider trade was on Oct 10, 2023, when they sold 341,241 shares at $0.00 per share.
Terri B. Sebree serves as Executive at Zynerba Pharmaceuticals, Inc. (ZYNE). They have executed 23 insider transactions totaling $62.4K over their tenure at the company.
Terri B. Sebree holds the position of Executive at Zynerba Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Terri B. Sebree has shown a selling trading pattern, with $22.0K in total purchases and $40.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Terri B. Sebree was on Feb 21, 2014, when they sold $1.2M worth of PATH shares. This transaction involved 179,182 shares at $6.80 per share.
Terri B. Sebree currently owns 255,000 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Terri B. Sebree's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Terri B. Sebree has 23 Form 4 filings on record as an insider at Zynerba Pharmaceuticals, Inc..
Set alerts for Terri B. Sebree and 40,000+ other insiders.